SRX Global Inc. Common Stock (SRXH)
Stock · AMEX · Consumer Staples
$1.19as of 10/16/2026
Price chart
Active signals
SRXH Signal Track Record
How signals performed across all stocks →What SRXH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band BreakdownActive now | 23 | -13.7% | 26% | October 8, 2026 |
| Bollinger Band Breakout | 19 | -21.1% | 16% | June 12, 2026 |
| Volume Spike | 13 | -24.9% | 0% | October 7, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -18.0% | 0% | January 16, 2024 |
| Any 20-session window (baseline) | -11.1% | 31% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SRXH
SRX Global Inc. operates an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. It leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across various sectors. The company is based in North Palm Beach, Florida.
- Sector
- Consumer Staples
- Industry
- Beverages (Production/Distribution)
- Employees
- 7
- Website
- srxhealth.com/
Fundamentals
- 1-day range
- $1.17$1.25
- Market cap
- $27.91M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-17.20
- Dividend yield
- —
- Beta
- 0.96
- Avg. volume
- 981.1K
- Ex-dividend date
- July 22, 2026
- Dividend pay date
- August 3, 2026
How SRX Global Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Dec 5, 2025 · via SEC EDGAR / Finnhub
SRX Global Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SRXHSRX Global Inc. Common Stock$1.19▼ 4.80%Market cap $27.91MP/E —$0.96$42.61
- EPSMEpsium Enterprise Limited Class A Ordinary Shares$1▼ 4.76%Market cap $19.75MP/E —$0.83$42.45
- WVVIPWillamette Valley Vineyards Inc. Series A Redeemable Preferred Stock$2.81▲ 5.24%Market cap $12.95MP/E 18.67$1.65$4
- WVVIWillamette Valley Vineyards Inc. Common Stock$2.05▲ 2.50%Market cap $11.95MP/E —$1.65$4
- REEDReed's Inc. Common Stock$0.39▼ 11.36%Market cap $9.12MP/E —$0.5065$12
- IBGInnovation Beverage Group Limited Ordinary Shares$0.81▼ 4.37%Market cap $1.96MP/E —$0.7101$24.7
- YHCLQR House Inc. Common Stock$1.72▼ 9.95%Market cap $1.96MP/E —$1.21$119
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SRXH SRX Global Inc. Common Stock | $27.91M | — | $1.19 | ▼ 4.80% | $0.96$42.61 |
| EPSM Epsium Enterprise Limited Class A Ordinary Shares | $19.75M | — | $1 | ▼ 4.76% | $0.83$42.45 |
| WVVIP Willamette Valley Vineyards Inc. Series A Redeemable Preferred Stock | $12.95M | 18.67 | $2.81 | ▲ 5.24% | $1.65$4 |
| WVVI Willamette Valley Vineyards Inc. Common Stock | $11.95M | — | $2.05 | ▲ 2.50% | $1.65$4 |
| REED Reed's Inc. Common Stock | $9.12M | — | $0.39 | ▼ 11.36% | $0.5065$12 |
| IBG Innovation Beverage Group Limited Ordinary Shares | $1.96M | — | $0.81 | ▼ 4.37% | $0.7101$24.7 |
| YHC LQR House Inc. Common Stock | $1.96M | — | $1.72 | ▼ 9.95% | $1.21$119 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- SRX Global Announces $2.5M Initial Investment To Seed Multi-Strategy Trading Fund In Joint Venture With 5T Tradingbenzinga · 10/8/2026
- SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX PlatformYahoo · 10/8/2026
- SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic MalignanciesYahoo · 10/7/2026
- SRX Global Inks Stock Purchase Agreement With Cero Therapeutics; To Acquire All Outstanding Stock Of Cero TherapeuticsBenzinga · 10/7/2026
- SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy KimYahoo · 10/6/2026
- SRX Global Announces $1.5M Commitment To Roll Out New Family Of Actively Managed ETFsBenzinga · 10/6/2026
- SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)Yahoo · 9/24/2026
- SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment WebinarYahoo · 9/23/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
SRX Global liquidates two investments, adds Onconetix stake
SRX Global informed shareholders that it is liquidating two portfolio investments. The company also announced a new investment in Onconetix, a Nasdaq‑listed firm. These actions change the composition of SRX's holdings and could influence future cash flows. The stock is currently near its $1.57 support level.
SRX Global liquidates two investments, adds Onconetix stake. SRX Global informed shareholders that it is liquidating two portfolio investments. The company also announced a new investment in Onconetix, a Nasdaq‑listed firm. These actions change the composition of SRX's holdings and could influence future cash flows. The stock is currently near its $1.57 support level.